Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Loratadine 10 mg Tablet, effervescent Asta Medica Arzneimittel GmbH., Wolfsberg, Austria Claratyne Effervescent Enoxaparin sodium 100 mg/mL in 0.2 mL, 0.4 mL, 0.6 mL, 0.8 mL, 1.0 mL Injection, pre-filled syringe Rhone-Poulenc Rorer Pharma Specialites, Maisons-Alfort, France Clexane Enoxaparin sodium 100 mg/mL in 0.6 mL, 0.8 mL, 1.0 mL Injection, ampoules Rhone-Poulenc Rorer Pharma Specialites, Maisons-Alfort, France Clexane Tuberculin PPD 27 mg, 81 mg and diluent Injection, powder, vial; Diluent, vial Connaught Laboratories Limited, Willowdale, Ontario, Canada Immucyst BCGImmunotherapeutic Omeprazole 10 mg, 20 mg Capsules Astra Pharmaceutical Production AB., Sodertalje, Sweden Losec Omeprazole 10 mg, 20 mg Capsules Astra Pharmaceutical Production AB., Sodertalje, Sweden Losec Filgrastim 0.3 mg in 1 mL Injection, vial F Hoffmann-La Roche Limited, Basle, Switzerland and Parke Davis Inc., Rochester, Michigan, United States of America Neupogen Filgrastim 0.3 mg in 1 mL Injection, pre-filled syringe F Hoffmann-La Roche Limited, Basle, Switzerland and Parke Davis Inc., Rochester, Michigan, United States of America Neupogen Caffeine 100 mg Tablet Pan Laboratories Pty Limited, Villawood, New South Wales, Australia No Doz Pluronic 17R4 0.02% w/v, sodium perborate 0.027% w/v Solution, contact lens Ciba Vision-Sterile Manufacturing, Mississauga, Ontario, Canada Softwear Plus Azithromycin dihydrate equivalent to 250 mg, 500 mg azithromycin base Tablets, film coated Pfizer Pty Limited, West Ryde, New South Wales, Australia and Pfizer Italiana SpA., Latina, Italy Zithromox Dated this 10th day of October 1997. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on 20 February 1997.